{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:33Z","timestamp":1788303993089,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cyto.2020.155226","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T05:42:13Z","timestamp":1597210933000},"page":"155226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis"],"prefix":"10.1016","volume":"135","author":[{"given":"P\u00e9ter","family":"K\u00f6rtvelyessy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Goihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Guttek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhart","family":"Schraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155226_b0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cyto.2020.155226_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00668","article-title":"Biomarkers of neurodegeneration in autoimmune-mediated encephalitis","author":"K\u00f6rtvelyessy","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cyto.2020.155226_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0507-9","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid","volume":"13","author":"Liba","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2020.155226_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cyto.2020.155226_b0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.braindev.2017.12.007","article-title":"Cytokine\/chemokine elevation during the transition phase from HSV encephalitis to autoimmune anti-NMDA receptor encephalitis","volume":"40","author":"Omae","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.cyto.2020.155226_b0030","doi-asserted-by":"crossref","unstructured":"T. Chaigneau, V. Calle, N. Cagnard, M. Holzenberger, Regulatory T cells delay disease progression in Alzheimer-like pathology, (2016) 1237\u20131251. 10.1093\/brain\/awv408.","DOI":"10.1093\/brain\/awv408"},{"key":"10.1016\/j.cyto.2020.155226_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2016.05.023","article-title":"Distinct intrathecal interleukin-17\/interleukin-6 activation in anti- N -methyl- D -aspartate receptor encephalitis","volume":"297","author":"Byun","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2020.155226_b0040","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1007\/s00415-012-6559-6","article-title":"LGI-1-positive limbic encephalitis: a clinicopathological study","volume":"259","author":"Schultze-Amberger","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.cyto.2020.155226_b0045","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation."},{"key":"10.1016\/j.cyto.2020.155226_b0050","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2020.155226_b0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cyto.2020.155226_b0060","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2020.155226_b0065","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2020.155226_b0070","doi-asserted-by":"crossref","unstructured":"H. Pr\u00fcss, C. Finke, M. H\u00f6ltje, D. Ph, J. Hofmann, C. Klingbeil, C. Probst, D. Ph, K. Borowski, G. Ahnert-hilger, D. Ph, L. Harms, J.M. Schwab, D. Ph, C.J. Ploner, D. Ph, W. Stoecker, J. Dalmau, D. Ph, NIH Public Access, 72 (2013) 902\u2013911. 10.1002\/ana.23689.N-Methyl-.","DOI":"10.1002\/ana.23689"},{"key":"10.1016\/j.cyto.2020.155226_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1 \u2013 associated cognitive impairment Presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2020.155226_b0080","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2020.155226_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis - epidemiology, diagnosis and management","author":"Koedel","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cyto.2020.155226_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","author":"Kowarik","year":"2012","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.cyto.2020.155226_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155226_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum","author":"M\u00fcller","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cyto.2020.155226_b0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/cei.12065","article-title":"Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome","volume":"172","author":"Pranzatelli","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2020.155226_b0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.cyto.2020.155226_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2017.01.020","article-title":"Markers of neuroinflammation associated with Alzheimer\u2019s disease pathology in older adults","author":"Popp","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.cyto.2020.155226_b0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00401-010-0671-4","article-title":"Abnormal tau phosphorylation in primary progressive multiple sclerosis","volume":"119","author":"Anderson","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cyto.2020.155226_b0125","author":"Frederiksen","year":"2012","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.cyto.2020.155226_b0130","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2020.155226_b0135","doi-asserted-by":"crossref","unstructured":"V. Yilmaz, P. Oflazer, F. Aysal, H. Durmus, K. Poulas, Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK, (2015). 10.1371\/journal.pone.0123546.","DOI":"10.1371\/journal.pone.0123546"},{"key":"10.1016\/j.cyto.2020.155226_b0140","doi-asserted-by":"crossref","unstructured":"C. Ulusoy, E. Kim, E. T\u00fcz\u00fcn, R. Huda, Y. Vuslat, K. Poulas, N. Trakas, L. Skriapa, A. Niarchos, R.T. Strait, F.D. Finkelman, Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice, (2014) 155\u2013163. 10.1016\/j.clim.2014.02.012.","DOI":"10.1016\/j.clim.2014.02.012"},{"key":"10.1016\/j.cyto.2020.155226_b0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2012.01.007","article-title":"The immunobiology and clinical characteristics of IgG4 related diseases","volume":"39","author":"Takahashi","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2020.155226_b0150","doi-asserted-by":"crossref","unstructured":"E. Della Torre, IgG4-related disease, in: Syst. Vasc. Curr. Status Perspect., 2016, pp. 311\u2013320. 10.1007\/978-3-319-40136-2_27.","DOI":"10.1007\/978-3-319-40136-2_27"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:33Z","timestamp":1760907513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620302428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"alternative-id":["S1043466620302428"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155226","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155226"}}